Independent Portfolio Consultants’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $111K | Sell |
912
-153
| -14% | -$18.6K | 0.05% | 401 |
|
|
2017
Q1 | $129K | Buy |
1,065
+340
| +47% | +$41.2K | 0.04% | 398 |
|
|
2016
Q4 | $89K | Buy |
+725
| New | +$89K | 0.03% | 465 |
|
|
2015
Q3 | – | Sell |
-70
| Closed | -$13K | – | 888 |
|
|
2015
Q2 | $13K | Sell |
70
-996
| -93% | -$185K | ﹤0.01% | 747 |
|
|
2015
Q1 | $185K | Sell |
1,066
-91
| -8% | -$15.8K | 0.04% | 379 |
|
|
2014
Q4 | $214K | Sell |
1,157
-1,350
| -54% | -$250K | 0.04% | 355 |
|
|
2014
Q3 | $416K | Sell |
2,507
-105
| -4% | -$17.4K | 0.11% | 282 |
|
|
2014
Q2 | $408K | Buy |
2,612
+155
| +6% | +$24.2K | 0.11% | 311 |
|
|
2014
Q1 | $373K | Sell |
2,457
-3,410
| -58% | -$518K | 0.12% | 322 |
|
|
2013
Q4 | $780K | Buy |
5,867
+115
| +2% | +$15.3K | 0.27% | 104 |
|
|
2013
Q3 | $668K | Sell |
5,752
-70
| -1% | -$8.13K | 0.27% | 119 |
|
|
2013
Q2 | $537K | Buy |
+5,822
| New | +$537K | 0.24% | 163 |
|